Search research articles
Contact Us
Filters
Showing results (91-100 of 109) with videos related to
Page
of 11
Sort By:
JCO Precision Oncology
|
January 31, 2024
Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights
Shivani Handa, Kyle A Farina, Michelle Becker, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 15, 2020
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies
Siyang Leng, Erin Moshier, Douglas Tremblay, et al.
American Journal of Hematology
|
July 6, 2024
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia
Metodi Balev, Victor Zibara, Grace Van Hyfte, et al.
Leukemia & Lymphoma
|
August 17, 2023
Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement
Dahniel Sastow, Joshua Tatarian, Yosef J R A Riazat-Kesh, et al.
Leukemia Research
|
June 19, 2022
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database
Noa Rippel, Douglas Tremblay, Nicole Zubizarreta, et al.
Cancer Medicine
|
September 18, 2020
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients
Douglas Tremblay, Carina Seah, Thomas Schneider, et al.
Leukemia Research
|
June 3, 2021
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database
Douglas Tremblay, Lukas Ronner, Nikolai Podoltsev, et al.
JAMA Network Open
|
December 5, 2022
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial
John Cafardi, Carole Miller, Howard Terebelo, et al.
Hematological Oncology
|
May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia
Georgio Medawar, Jean-Sebastien Anoma, Elizabeth Hill, et al.
Thrombosis Research
|
August 28, 2020
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19
Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 109) with videos related to
Sort By:
Page
of 11
JCO Precision Oncology
|
January 31, 2024
Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic Insights
Shivani Handa, Kyle A Farina, Michelle Becker, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 15, 2020
Timing of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Current Therapies
Siyang Leng, Erin Moshier, Douglas Tremblay, et al.
American Journal of Hematology
|
July 6, 2024
Evaluating the role of Day 14 bone marrow biopsy and European LeukemiaNet risk classification in predicting overall and relapse-free survival in acute myeloid leukemia
Metodi Balev, Victor Zibara, Grace Van Hyfte, et al.
Leukemia & Lymphoma
|
August 17, 2023
Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvement
Dahniel Sastow, Joshua Tatarian, Yosef J R A Riazat-Kesh, et al.
Leukemia Research
|
June 19, 2022
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database
Noa Rippel, Douglas Tremblay, Nicole Zubizarreta, et al.
Cancer Medicine
|
September 18, 2020
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients
Douglas Tremblay, Carina Seah, Thomas Schneider, et al.
Leukemia Research
|
June 3, 2021
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database
Douglas Tremblay, Lukas Ronner, Nikolai Podoltsev, et al.
JAMA Network Open
|
December 5, 2022
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial
John Cafardi, Carole Miller, Howard Terebelo, et al.
Hematological Oncology
|
May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia
Georgio Medawar, Jean-Sebastien Anoma, Elizabeth Hill, et al.
Thrombosis Research
|
August 28, 2020
Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19
Leonard Naymagon, Nicole Zubizarreta, Jonathan Feld, et al.
Page
of 11